Lab Automation Market Size & Growth Forecast 2027–2036, By Segments (Process, End-use, Automation Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Lab Automation Market size was over USD 10 billion in 2026 and is likely to grow at a 8.84% CAGR between 2027 and 2036, crossing USD 23.33 billion by 2036. The industry revenue for 2027 is assessed at USD 10.74 billion.

• Base Year Value (2026): USD 10 billion
• CAGR (2027-2036): 8.84%
• Forecast Year Value (2036): USD 23.33 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Lab Automation Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 38.69% share in 2026, supported by advanced laboratory infrastructure and automation adoption across research, diagnostics, and testing workflows.
  • Asia Pacific is projected to grow at a 7.68% CAGR, driven by laboratory modernization, rising capacity investment, and automated workflow adoption.

• Segment Momentum:

  • Continuous Flow held a 58.12% share in 2026 because it supports uninterrupted, high-throughput laboratory operations that prioritize efficiency, repeatability, and streamlined workflow management.
  • Immunoassay Analysis is expanding rapidly due to increasing demand for automated, method-sensitive testing workflows that require greater precision, consistency, and controlled processing support.

• Market Expansion Drivers:

  • Rising demand for high-throughput screening accelerating adoption of fully automated laboratory systems.
  • Increasing focus on laboratory efficiency and workflow standardization driving automation investments.
  • Growing integration of AI-enabled robotics improving laboratory data accuracy and operational scalability.

• Leading Market Participants:

  Top companies in the lab automation market include Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Agilent Technologies, Inc. (United States), QIAGEN N.V. (Netherlands), Eppendorf SE (Germany), Hudson Robotics, Inc. (United States), BMG LABTECH GmbH (Germany), Revvity, Inc. (PerkinElmer, Inc.) (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 10 billion
  • 2027 Estimated Market Size: USD 10.74 billion.
  • Projected Market Size: USD 23.33 billion by 2036
  • Growth Forecasts: 8.84% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Continuous Flow (Process) | Clinical Chemistry Analysis (End-use) | Total Automation Systems (Automation Type)
  • Emerging Opportunity Segment: Discrete Processing (Process) | Immunoassay Analysis (End-use) | Total Automation Systems (Automation Type)

Market Growth Drivers and Industry Trends

Rising demand for high-throughput screening accelerating adoption of fully automated laboratory systems

The growing need to process large volumes of samples efficiently is strengthening the lab automation market as laboratories increasingly require systems capable of performing repetitive procedures with speed and consistency. Automated liquid handling, sample preparation, analysis, and material-transfer systems can reduce manual intervention while supporting continuous processing across screening workflows. High-throughput environments particularly benefit from automation because standardized machine-driven operations can help laboratories manage substantial workloads while maintaining consistent processing conditions.

Increasing focus on laboratory efficiency and workflow standardization driving automation investments

Laboratories are placing greater emphasis on improving resource utilization, reducing process variability, and standardizing routine procedures, which will propel the lab automation market by encouraging investment in automated workflows. Automated systems can coordinate multiple stages of laboratory operations, reduce dependence on repetitive manual tasks, and establish consistent protocols across samples and testing processes. Standardization is particularly valuable in research, diagnostic, pharmaceutical, and biotechnology laboratories where reproducibility and traceability are important components of reliable laboratory operations.

Growing integration of AI-enabled robotics improving laboratory data accuracy and operational scalability

The combination of artificial intelligence, robotics, and laboratory information systems is expanding the capabilities of automated laboratories, supporting the lab automation market through more intelligent process control and decision support. AI-enabled robotic systems can assist with sample identification, handling, scheduling, and workflow optimization while using operational data to improve task coordination and reduce processing errors. Greater integration between robotics and digital laboratory platforms also enables facilities to scale automated workflows across multiple procedures while maintaining centralized monitoring and data management.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising demand for high-throughput screening accelerating adoption of fully automated laboratory systems	1.90%	Moderate	North America, Europe	High	Near Term
Increasing focus on laboratory efficiency and workflow standardization driving automation investments	1.60%	Moderate	Asia Pacific, North America	High	Mid Term
Growing integration of AI-enabled robotics improving laboratory data accuracy and operational scalability	1.30%	Moderate	Europe, Asia Pacific	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

The lab automation market was led by North America, which accounted for a 38.69% share in 2026, underpinned by sophisticated laboratory infrastructure, strong demand for high-throughput workflows, and widespread adoption of advanced analytical technologies. Research institutions, diagnostic laboratories, pharmaceutical operations, and other testing environments are increasingly emphasizing automation to improve workflow consistency, reduce manual intervention, and enhance operational efficiency. The region's mature life sciences ecosystem also supports investment in automated sample handling, liquid management, data integration, and laboratory robotics. Growing pressure to improve productivity while maintaining accuracy and reproducibility is encouraging laboratories to modernize processes and expand automation capabilities.

Asia Pacific is projected to experience the fastest growth as laboratories across healthcare, pharmaceutical research, biotechnology, and industrial testing increasingly adopt automated workflows. Expanding research infrastructure and rising demand for efficient diagnostic and analytical services are creating favorable conditions for laboratory automation. The modernization of healthcare and scientific facilities is also encouraging investment in equipment capable of streamlining repetitive procedures and improving laboratory productivity. Moreover, growing life sciences activity, increasing emphasis on research capabilities, and broader adoption of digital laboratory technologies are supporting the transition from manual processes toward integrated and automated laboratory environments.

Key Country Insights

United States

High-Throughput Laboratory Systems

The U.S. continues to modernize laboratory operations through robotic workflows, AI-supported analytics, and integrated automation platforms. Research organizations and pharmaceutical laboratories increasingly invest in scalable solutions that improve productivity, reproducibility, and data management.

Japan

Advanced Robotics Integration

Japan leverages its robotics expertise to expand automated laboratory operations across life sciences and healthcare research. Laboratories in Japan increasingly adopt compact, precision-focused automation platforms that support reliable experimentation and efficient resource utilization.

South Korea

Smart Research Infrastructure

South Korea strengthens laboratory automation through investments in biotechnology research and digital laboratory capabilities. Research institutions across South Korea increasingly deploy connected automation platforms that streamline testing workflows and support collaborative scientific research.

Germany

Precision Workflow Optimization

Germany emphasizes laboratory automation that enhances analytical accuracy and operational consistency across research and industrial laboratories. German organizations increasingly integrate automated sample handling with digital laboratory management systems to improve process efficiency.

France

Research Process Digitalization

France prioritizes laboratory automation that improves research quality and operational efficiency across academic and clinical environments. Laboratories in France increasingly adopt integrated automation technologies to reduce manual intervention while supporting standardized analytical procedures.

Italy

Laboratory Modernization Focus

Italy advances laboratory automation by upgrading research infrastructure in healthcare, pharmaceutical, and industrial sectors. Organizations in Italy increasingly implement automated instrumentation and workflow management solutions to improve laboratory productivity and result consistency.

Segment Leadership and Growth Trends

 

Process Segment Analysis: Continuous Flow (Largest Segment) vs Discrete Processing (Fastest-Growing Segment)

Continuous flow held the largest share of the lab automation market, representing 58.12% in 2026. Its leadership is supported by the need for consistent, high-throughput laboratory workflows in applications that require uninterrupted processing and reliable handling of samples or materials. Automation within continuous processes can reduce manual intervention, improve workflow consistency, and support efficient laboratory operations. The growing focus on productivity, reproducibility, and process standardization across laboratories further reinforces the adoption of continuous flow automation, particularly in environments where operational efficiency and dependable throughput are critical.

Discrete processing is experiencing the fastest growth as laboratories increasingly automate individual analytical and preparation steps that require flexibility and precise task management. Automated handling of separate samples, reagents, and testing procedures can reduce repetitive manual work while improving accuracy and workflow coordination. This approach is particularly relevant to laboratories managing diverse testing requirements and increasingly complex analytical workloads. Advances in robotic handling, software integration, and intelligent laboratory systems are further enabling broader adoption of discrete automation.

End-use Segment Analysis: Clinical Chemistry Analysis (Largest Segment) vs Immunoassay Analysis (Fastest-Growing Segment)

Clinical chemistry analysis dominated the lab automation market, accounting for a 29.94% share in 2026. Its leading position reflects the substantial volume and repetitive nature of biochemical testing performed in diagnostic laboratories. Automation supports efficient sample preparation, processing, analysis, and result management, helping laboratories handle routine workloads while maintaining consistency and reducing opportunities for manual error. Increasing demand for laboratory efficiency and standardized diagnostic workflows continues to encourage automation across clinical chemistry operations, reinforcing the segment's established market position.

Immunoassay analysis is the fastest-growing end-use segment, benefiting from expanding demand for automated testing workflows that can manage sensitive and technically demanding diagnostic procedures. Automation helps improve consistency in reagent handling, sample processing, and analytical operations while supporting laboratories facing increasing testing volumes. The broader adoption of immunoassay-based diagnostics across healthcare applications, combined with advances in laboratory instrumentation and workflow integration, is creating favorable conditions for automation within this segment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Process	Continuous Flow, Discrete Processing	Continuous Flow	Discrete Processing
End-use	Clinical Chemistry Analysis, Photometry & Fluorometry, Immunoassay Analysis, Electrolyte Analysis, Others	Clinical Chemistry Analysis	Immunoassay Analysis
Automation Type	Total Automation Systems, Modular Automation Systems	Total Automation Systems	Total Automation Systems

Competitive Landscape and Market Positioning

Leading companies in the lab automation market:

1. Thermo Fisher Scientific Inc. (United States)

2. Danaher Corporation (United States)

3. F. Hoffmann-La Roche Ltd (Switzerland)

4. Siemens Healthineers AG (Germany)

5. Agilent Technologies Inc. (United States)

6. QIAGEN N.V. (Netherlands)

7. Eppendorf SE (Germany)

8. Hudson Robotics Inc. (United States)

9. BMG LABTECH GmbH (Germany)

10. Revvity Inc. (PerkinElmer Inc.) (United States)

The lab automation market is advancing through increased integration of robotics and intelligent laboratory systems. Automation-driven workflows are improving efficiency and reducing manual errors. Continuous innovation in laboratory technologies is supporting faster experimental processing, while expanding digital ecosystems are enhancing research productivity and scalability.

Industry Development/News

Company Name	Date	Key Development
Tecan	May-26	Tecan established direct sales and service operations in India with a new facility in Gurugram. This geographic expansion strengthens the company's commercial infrastructure in a high-growth region, facilitating the adoption of its automated liquid handling and lab automation solutions across clinical and life science research sectors.
EarthOptics	May-26	EarthOptics opened a 14,500-square-foot soil analytics facility in the Raleigh-Durham area. The site integrates laboratory infrastructure with automated analytics workflows, significantly increasing the company's capacity for high-throughput soil testing and enhancing its ability to provide data-driven services for the agricultural and environmental sectors.
HighRes and Opentrons Labworks	May-26	HighRes and Opentrons Labworks developed an AI agent-to-agent workflow that bridges experimental intent with robotic execution. By integrating orchestration software with physical automation hardware, the partnership enables more autonomous laboratory environments, allowing for greater scalability in complex, AI-driven scientific experimentation.
Automata Technologies	Jan-26	Automata Technologies secured $45 million in Series C funding, including a strategic investment from Danaher Corp. The capital will accelerate the development of its closed-loop laboratory automation software and expand global operations, reinforcing its market position in end-to-end, integrated automated workflow solutions.
Eppendorf	Sep-25	Eppendorf launched the VisioNize box 2, a digital connectivity hub designed to facilitate remote monitoring and management of laboratory devices. The solution provides a scalable approach to digital lab integration, enhancing operational efficiency and safety for research facilities by centralizing data management across diverse laboratory hardware.
Opentrons Labworks	Sep-25	Opentrons Labworks entered a strategic partnership with Beckman Coulter Life Sciences and HSE•AG to optimize automated nucleic acid purification workflows. The collaboration leverages advanced robotics to enhance liquid handling precision, streamlining critical diagnostic processes and improving reproducibility for high-throughput life sciences research applications.
Cenevo	Aug-25	Titian Software and Labguru merged to form Cenevo, consolidating their respective informatics and automation platforms. The integration creates a unified ecosystem for digital lab management and workflow orchestration, strengthening the company's capability to deliver data-driven, end-to-end automation solutions for research and clinical environments.
Merck	Jul-25	Merck launched the AAW Automated Assay Workstation, developed in partnership with Opentrons. The plug-and-play platform is specifically designed to provide modular automation for pharmaceutical and biotech laboratories, aiming to accelerate the pace of scientific discovery through accessible, high-performance liquid handling and workflow execution.
QIAGEN	Apr-25	QIAGEN announced the rollout of the QIAmini, QIAsprint Connect, and QIAsymphony Connect platforms, slated for release through 2026. These instruments are designed to scale sample preparation from low to high-throughput workflows, significantly bolstering the company’s automated capabilities in oncology and genomics-focused clinical research.
Tecan	Jan-25	Tecan introduced an automated liquid handling platform featuring AI-driven precision and workflow capabilities. The system is engineered to enhance laboratory throughput and reproducibility, specifically targeting regulated environments that require high standards of data integrity and consistent performance in automated diagnostic and research protocols.